Physician profile
Allison Wallace
NPI 1306300785
$2,789.85
in general payments reported to CMS, 2019-2025
14 companies · $822 in 2025
The $822 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $58.39 · 2022: $564 · 2023: $1,143 · 2024: $203 · 2025: $822.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,353 · Food and Beverage: $815.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,353.03 |
| Food and Beverage | $814.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $2,079.76 | 2023-2025 | |
| Abbvie INC. | $235.01 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $76.72 | 2022 | |
| Bausch Health US, LLC | $75.64 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $58.84 | 2021-2022 | |
| Depuy Synthes Sales INC. | $50.75 | 2023 | Teligen, Conduit |
| Indivior INC. | $41.95 | 2022 | |
| Stryker Corporation | $37.05 | 2025 | Adherus Autospray Dural Sealant |
| Sunovion Pharmaceuticals INC. | $33.20 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $32.19 | 2022 | |
| Lundbeck LLC | $20.60 | 2022 | |
| Janssen Pharmaceuticals, INC | $16.82 | 2021 | |
| Almatica Pharma LLC | $16.68 | 2022 | |
| Alkermes, INC. | $14.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Wallace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.